Cargando…

Comparative Evaluation of Two Venous Sampling Techniques for the Assessment of Pancreatic Insulin and Zinc Release upon Glucose Challenge

Advances in noninvasive imaging modalities have provided opportunities to study β cell function through imaging zinc release from insulin secreting β cells. Understanding the temporal secretory pattern of insulin and zinc corelease after a glucose challenge is essential for proper timing of administ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pillai, Anil Kumar, Silvers, William, Christensen, Preston, Riegel, Matthew, Adams-Huet, Beverley, Lingvay, Ildiko, Sun, Xiankai, Öz, Orhan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530279/ https://www.ncbi.nlm.nih.gov/pubmed/26273676 http://dx.doi.org/10.1155/2015/789359

Ejemplares similares

Insulin-Based Versus Triple Oral Therapy for Newly Diagnosed Type 2 Diabetes: Which is better?
por: Lingvay, Ildiko, et al.
Publicado: (2009)

β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy
por: Harrison, Lindsay B., et al.
Publicado: (2012)

Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study
por: Patel, Sapna, et al.
Publicado: (2019)

Correlates of Insulin Resistance in Nascent Metabolic Syndrome
por: Adams-Huet, Beverley, et al.
Publicado: (2023)

Copper-67 radioimmunotheranostics for simultaneous immunotherapy and immuno-SPECT
por: Hao, Guiyang, et al.
Publicado: (2021)

Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors
por: Moeendarbari, Sina, et al.
Publicado: (2016)

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures
por: Lingvay, Ildiko, et al.
Publicado: (2017)

Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used
por: Norwood, Paul, et al.
Publicado: (2017)

An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes
por: Lingvay, Ildiko, et al.
Publicado: (2022)

Abstract 3: CGM-derived parameters for once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-Naïve patients with T2D
por: Kunder, Sushil, et al.
Publicado: (2022)

Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy
por: Lingvay, Ildiko, et al.
Publicado: (2021)

Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial
por: Lingvay, Ildiko, et al.
Publicado: (2017)

Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)
por: Desouza, Cyrus, et al.
Publicado: (2020)

Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes
por: Mora, Pablo F, et al.
Publicado: (2020)

A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100
por: Lingvay, Ildiko, et al.
Publicado: (2021)

OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes
por: Mora, Pablo, et al.
Publicado: (2020)

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial
por: Bajaj, Harpreet S., et al.
Publicado: (2021)

Response to Comment on: Harrison et al. β-Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy. Diabetes Care 2012;35:1406–1412
por: Harrison, Lindsay B., et al.
Publicado: (2013)

Waiting upon the Remedy
por: Preston, F.
Publicado: (1894)

Protamine Zinc Insulin
Publicado: (1937)

Protamine Zinc Insulin
por: Bose, J. P.
Publicado: (1938)

Zinc Protamine Insulin
por: Dunlop, D. M.
Publicado: (1938)

Increased Adipocyte Hypertrophy in Patients with Nascent Metabolic Syndrome
por: Jialal, Ishwarlal, et al.
Publicado: (2023)

Rapid Improvement in Diabetes After Gastric Bypass Surgery: Is it the diet or surgery?
por: Lingvay, Ildiko, et al.
Publicado: (2013)

Chronic Pancreatitis Associated With a Variant of CFTR Gene Treated With Total Pancreatectomy and Autologous Islet Cell Transplantation
por: Agarwal, Shubham, et al.
Publicado: (2023)

Serial Non-Invasive Assessment of Antibody Induced Nephritis in Mice Using Positron Emission Tomography
por: Hao, Guiyang, et al.
Publicado: (2013)

Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy
por: Mulgaonkar, Aditi, et al.
Publicado: (2023)

Rationale and design of the phase 3a development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes
por: Philis‐Tsimikas, Athena, et al.
Publicado: (2022)

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14
por: Pratley, Richard E., et al.
Publicado: (2019)

Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial
por: Rodbard, Helena W, et al.
Publicado: (2018)

Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance
por: Almandoz, Jaime P., et al.
Publicado: (2020)

Upon the Difference of Temperature between Venous and Arterial Blood
por: Liebig, G. V.
Publicado: (1853)

Impact of PTBP1 rs11085226 on glucose-stimulated insulin release in adult Danes
por: Hansen, Tue H, et al.
Publicado: (2015)

Preventing hospital associated venous thromboembolism
por: Hunt, Beverley J
Publicado: (2019)

Nephrin Is Expressed on the Surface of Insulin Vesicles and Facilitates Glucose-Stimulated Insulin Release
por: Fornoni, Alessia, et al.
Publicado: (2010)

Non-insulin determinant pathways maintain glucose homeostasis upon metabolic surgery
por: Lu, Zongshi, et al.
Publicado: (2018)

Zinc Status Affects Glucose Homeostasis and Insulin Secretion in Patients with Thalassemia
por: Fung, Ellen B., et al.
Publicado: (2015)

Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre‐trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin
por: Meneghini, L., et al.
Publicado: (2019)

First-Line Use of Vemurafenib to Enable Thyroidectomy and Radioactive Iodine Ablation for BRAF-Positive Metastatic Papillary Thyroid Carcinoma: A Case Report
por: Dao, Bao D., et al.
Publicado: (2015)

An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression
por: Lingvay, Ildiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rggiagvddc1situghcdsjrd309